DZE: Implant, Endosseous, Root-Form

Product code DZE, “Implant, Endosseous, Root-Form” in FDA's classification database, is a Class II device type under 21 CFR 872.3640 (endosseous dental implant), reviewed by FDA's Dental panel. FDA's 510(k) database lists 1,549 clearances under DZE, 568 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
DZE
Regulation
21 CFR 872.3640
Class
II
Panel
Dental
Clearances
1,549
Most recent
Sep 17, 2026
Median review, last 2 years
193 days
Third-party review
Not eligible
Implant
Yes

What it covers

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

The identification in 21 CFR 872.3640, endosseous dental implant. FDA gives DZE no definition of its own, so the regulation’s describes it.

FDA flags DZE devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K261392TriActive Dental Implant SystemParagon Implant Mfg., LLCSep 17, 2026Abbreviated
K260463ZEROS Dental Implant SystemZeros Co., Ltd.Aug 19, 2026Special
K251188UNIQA® Dental Implants SystemUniqa Dental, Ltd.Jun 25, 2026Traditional
K251232MegaGen Zygoma Dental Implant SystemMegagen Implant Co., Ltd.Jun 18, 2026Traditional
K250806Dental Implant SystemA.B. Dental Devices , Ltd.Jun 18, 2026Traditional
K260006INOSS SystemInosys, Inc.Jun 17, 2026Traditional
K252731Promimic ZrP Surface Dental Implant; Promimic ZrP + HAnano Surface Dental ImplantPromimic ABMay 12, 2026Traditional
K252031Adin Long Dental Implant SystemAdin Dental Implant Systems , Ltd.Mar 23, 2026Traditional
K253334ZENEX Implant System_Short (R-System)Izenimplant Co., Ltd.Mar 16, 2026Traditional
K252168Straumann® BLC Implants - Indication WideningInstitut Straumann AGMar 10, 2026Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 1,549 with a free account)

Clearances by year

568 DZE 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)14207
202531184
202440222
202335248
202234243
202134182
202041230
201931231
201841200
201748223
201640219
201536215
201436265
201342195
201239174
201126194

Who submits

225 applicants cleared a DZE device since 2011. 35% of the clearances went to applicants in United States, then South Korea (21%), Israel (10%) and Switzerland (7%). By type: Traditional 90%, Special 5% and Abbreviated 5%.

ApplicantClearances since 2011
Dentis Co., Ltd.16
Institut Straumann AG16
Megagen Implant Co., Ltd.16
Jjgc Industria E Comercio DE Materiais Dentarios S.A.13
Nobel Biocare AB13
Southern Implants (Pty), Ltd.12
Hiossen, Inc.11
Innobiosurg Co., Ltd.10

How FDA classifies it

(1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)

(2) Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:

(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;

(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;

(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;

(iv) The device must be demonstrated to be biocompatible;

(v) Sterility testing must demonstrate the sterility of the device;

(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;

(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;

(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and

(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

From 21 CFR 872.3640. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 872.3640 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DZE clearances declared.

Ask about DZE

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about DZE

What is FDA product code DZE?

Product code DZE, “Implant, Endosseous, Root-Form” in FDA's classification database, is a Class II device type under 21 CFR 872.3640 (endosseous dental implant), reviewed by FDA's Dental panel. FDA's 510(k) database lists 1,549 clearances under DZE, 568 of them since 2011.

How many 510(k) clearances are there under DZE?

FDA’s 510(k) database listed 1,549 clearances under DZE as of Oct 29, 2026, 568 of them decided since 2011; the most recent decision was Sep 17, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a DZE 510(k)?

For the 57 DZE clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 193 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most DZE clearances?

Since 2011: Dentis Co., Ltd. (16), Institut Straumann AG (16), Megagen Implant Co., Ltd. (16), Jjgc Industria E Comercio DE Materiais Dentarios S.A. (13) and Nobel Biocare AB (13). 225 applicants have cleared a DZE device in that time.

Sources

  1. FDA product classification: DZE · Product Classification database
  2. 21 CFR 872.3640: Endosseous dental implant · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for DZE · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow DZEGet an email when FDA clears, recalls or publishes guidance for DZE devices.

Know what FDA already cleared.